Inositol to Reduce Retinopathy of Prematurity

Stopped Study terminated due to safety concerns; participant follow up will continue until March 2018

Conditions

• Retinopathy of Prematurity (ROP)

Interventions

• DRUG: myo-Inositol 5% Injection
• DRUG: Placebo

Sponsor

NICHD Neonatal Research Network

Collaborators

• [object Object]
• [object Object]